✦ LIBER ✦

Uptake and binding of teniposide (VM 26) in Krebs II ascites cells

✍ Scribed by Mohamed Hamza; Pierre Canal; Roland Bugat; Georges Soula; Louis Douste-Blazy

Book ID: 115779433
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 514 KB
Volume: 36
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(87)90042-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and efficacy of i.v. an

Pharmacokinetics and efficacy of i.v. and i.p. VM26 chemotherapy in mice bearing krebs II ascitic tumors

✍ Canal, P.; Bugat, R.; Rokoszak, B.; Berg, D.; Soula, G.; Roche, H. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 652 KB

Mutagenicity and clastogenicity of tenip

Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK+/−−3.7.2C mouse lymphoma cells

✍ David M. DeMarini; Karen H. Brock; Carolyn L. Doerr; Martha M. Moore 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Pharmacokinetics of teniposide (VM 26) a

Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma

✍ P. Canal; R. Bugat; C. Michel; H. Roche; G. Soula; P. F. Combes 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 315 KB

Nine patients with ovarian carcinoma and malignant ascites treated with IV teniposide chemotherapy (30 mg/m2/30 min) entered this study. Plasma and peritoneal fluid levels were measured by an HPLC method with electrochemical detection. Plasma decay kinetics followed a triexponential function. A high

Cisplatin and teniposide (VM26) chemothe

Cisplatin and teniposide (VM26) chemotherapy for brain metastases in lung cancer. Preliminary results of a phase II trial

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Teniposide (VM-26), an overlooked highly

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Unexpected high toxicity in a phase II s

Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC)

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 184 KB